Covishield Impact During Delta Surge: Good news has come out about the Indian vaccine against the corona virus (Covishield Vaccine). According to a study published in an international newspaper, at a time when Corona Falls was at its peak, Kovishield was found to be very effective in fighting the virus and acted as a protective shield. The results of this study were published in the international medical journal The Lancet Infectious Diseases. printed It’s done. The survey was conducted by the Indian Survey between April-May 2021, when the Delta species caused a stir in the country.
According to a study conducted by the Translational Health Science and Technology Institute, Covishield was helpful for 63% of people who took the entire dosage. At the same time, it was found that 81% were active in intermediate or chronic diseases. In this study, comparisons were made between 2379 cases of the disease. It was found that the immune system provided by the vaccine was weakened against different strains. adequate protection (weak protection) can be paid for. Not only that, the vaccine prevents severe to severe infections and the need for hospitalization. The Ministry of Health has stated that the study provides comprehensive information on the effectiveness of global vaccines.
The results of this study have been released at a time when new corona cases are ahead of the world. Types of Omicron (Omicron variant) or B.1.1.529 knocked. So far, cases of this nature, which first appeared in South Africa, have been found in 19 countries. A large number of 77 people have been found in South Africa. The World Health Organization (WHO) calls this a “type of anxiety”. Since then, alarm bells have been sounded around the world. The WHO said the Omicron reform was a “major threat” to the world.
The WHO emphasized that it would be difficult to determine at this stage how communicable and potentially contagious they can be. However, not a single Omicron case has been reported in India. Indian Health Minister Mansukh Mandaviya told Rajya Sabha that not a single Omicron case has been found in India.
Extra dose can be done within 6 months
Adar Poonawalla, head of the Serum Institute of India, the company that manufactures Covishield in India, said scientists at Oxford are examining how Covishield works on Omicron models. We can introduce a new vaccine in 6 months, which acts as an additional dose.